Tissue remodelling in breast cancer: Human mast cell tryptase as an initiator of myofibroblast differentiation

Anita Mangia, Andrea Malfettone, Roberta Rossi, Angelo Paradiso, Girolamo Ranieri, Giovanni Simone, Leonardo Resta

Research output: Contribution to journalArticle

Abstract

Aims: Cancerogenesis is characterized by increase of differentiated myofibroblasts. Mast cells (MCs) exert powerful effects on fibroblasts through a variety of mediators. We investigated α-smooth-muscle actin (α-SMA+) and CD34+ fibroblasts, density of toluidine blue-stained (MCs-TB) and tryptase-immunolabelled MCs (MCs-Try) in 30 primary breast tumours. Methods and results: Tumour (T), peri-tumoral (PT) and non-tumoral (NT) tissue was studied by immunohistochemistry and electron microscopy. MCs-TB and MCs-Try increased gradually from NT to PT and T and the comparison between the three compartments varied significantly. Degranulated MCs were present more significantly in NT and adjacent PT than T. Transition between NT, PT and T was marked by increasing α-SMA+ fibroblasts and slow disappearance of CD34+ stromal cells. In NT, CD34+ fibroblasts correlated with low density both of MCs-TB and intact MCs-Try (P=0.0346 and P=0.0409, respectively). In T, the few preserved CD34+ fibroblasts were associated with low-density degranulated MCs-Try (P=0.0173). The α-SMA+ fibroblasts correlated with high density of intact MCs-Try in PT, and with high density of degranulated MCs-Try in T (P=0.0289), also confirmed by ultrastructural analysis. Conclusions: This preliminary investigation suggests that during breast cancer progression the MCs may contribute to stromal remodelling and differentiation of myofibroblasts, through tryptase released in stromal microenvironment.

Original languageEnglish
Pages (from-to)1096-1106
Number of pages11
JournalHistopathology
Volume58
Issue number7
DOIs
Publication statusPublished - Jun 2011

Fingerprint

Tryptases
Myofibroblasts
Mast Cells
Breast Neoplasms
Fibroblasts
Tolonium Chloride
Stromal Cells
Smooth Muscle
Actins
Electron Microscopy
Immunohistochemistry

Keywords

  • α-SMA-positive myofibroblasts
  • Breast cancer
  • Toluidine blue
  • Tryptase-positive mast cells

ASJC Scopus subject areas

  • Histology
  • Pathology and Forensic Medicine

Cite this

Tissue remodelling in breast cancer : Human mast cell tryptase as an initiator of myofibroblast differentiation. / Mangia, Anita; Malfettone, Andrea; Rossi, Roberta; Paradiso, Angelo; Ranieri, Girolamo; Simone, Giovanni; Resta, Leonardo.

In: Histopathology, Vol. 58, No. 7, 06.2011, p. 1096-1106.

Research output: Contribution to journalArticle

Mangia, Anita ; Malfettone, Andrea ; Rossi, Roberta ; Paradiso, Angelo ; Ranieri, Girolamo ; Simone, Giovanni ; Resta, Leonardo. / Tissue remodelling in breast cancer : Human mast cell tryptase as an initiator of myofibroblast differentiation. In: Histopathology. 2011 ; Vol. 58, No. 7. pp. 1096-1106.
@article{fb303838d02047988d53ce4ccfd089bd,
title = "Tissue remodelling in breast cancer: Human mast cell tryptase as an initiator of myofibroblast differentiation",
abstract = "Aims: Cancerogenesis is characterized by increase of differentiated myofibroblasts. Mast cells (MCs) exert powerful effects on fibroblasts through a variety of mediators. We investigated α-smooth-muscle actin (α-SMA+) and CD34+ fibroblasts, density of toluidine blue-stained (MCs-TB) and tryptase-immunolabelled MCs (MCs-Try) in 30 primary breast tumours. Methods and results: Tumour (T), peri-tumoral (PT) and non-tumoral (NT) tissue was studied by immunohistochemistry and electron microscopy. MCs-TB and MCs-Try increased gradually from NT to PT and T and the comparison between the three compartments varied significantly. Degranulated MCs were present more significantly in NT and adjacent PT than T. Transition between NT, PT and T was marked by increasing α-SMA+ fibroblasts and slow disappearance of CD34+ stromal cells. In NT, CD34+ fibroblasts correlated with low density both of MCs-TB and intact MCs-Try (P=0.0346 and P=0.0409, respectively). In T, the few preserved CD34+ fibroblasts were associated with low-density degranulated MCs-Try (P=0.0173). The α-SMA+ fibroblasts correlated with high density of intact MCs-Try in PT, and with high density of degranulated MCs-Try in T (P=0.0289), also confirmed by ultrastructural analysis. Conclusions: This preliminary investigation suggests that during breast cancer progression the MCs may contribute to stromal remodelling and differentiation of myofibroblasts, through tryptase released in stromal microenvironment.",
keywords = "α-SMA-positive myofibroblasts, Breast cancer, Toluidine blue, Tryptase-positive mast cells",
author = "Anita Mangia and Andrea Malfettone and Roberta Rossi and Angelo Paradiso and Girolamo Ranieri and Giovanni Simone and Leonardo Resta",
year = "2011",
month = "6",
doi = "10.1111/j.1365-2559.2011.03842.x",
language = "English",
volume = "58",
pages = "1096--1106",
journal = "Histopathology",
issn = "0309-0167",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Tissue remodelling in breast cancer

T2 - Human mast cell tryptase as an initiator of myofibroblast differentiation

AU - Mangia, Anita

AU - Malfettone, Andrea

AU - Rossi, Roberta

AU - Paradiso, Angelo

AU - Ranieri, Girolamo

AU - Simone, Giovanni

AU - Resta, Leonardo

PY - 2011/6

Y1 - 2011/6

N2 - Aims: Cancerogenesis is characterized by increase of differentiated myofibroblasts. Mast cells (MCs) exert powerful effects on fibroblasts through a variety of mediators. We investigated α-smooth-muscle actin (α-SMA+) and CD34+ fibroblasts, density of toluidine blue-stained (MCs-TB) and tryptase-immunolabelled MCs (MCs-Try) in 30 primary breast tumours. Methods and results: Tumour (T), peri-tumoral (PT) and non-tumoral (NT) tissue was studied by immunohistochemistry and electron microscopy. MCs-TB and MCs-Try increased gradually from NT to PT and T and the comparison between the three compartments varied significantly. Degranulated MCs were present more significantly in NT and adjacent PT than T. Transition between NT, PT and T was marked by increasing α-SMA+ fibroblasts and slow disappearance of CD34+ stromal cells. In NT, CD34+ fibroblasts correlated with low density both of MCs-TB and intact MCs-Try (P=0.0346 and P=0.0409, respectively). In T, the few preserved CD34+ fibroblasts were associated with low-density degranulated MCs-Try (P=0.0173). The α-SMA+ fibroblasts correlated with high density of intact MCs-Try in PT, and with high density of degranulated MCs-Try in T (P=0.0289), also confirmed by ultrastructural analysis. Conclusions: This preliminary investigation suggests that during breast cancer progression the MCs may contribute to stromal remodelling and differentiation of myofibroblasts, through tryptase released in stromal microenvironment.

AB - Aims: Cancerogenesis is characterized by increase of differentiated myofibroblasts. Mast cells (MCs) exert powerful effects on fibroblasts through a variety of mediators. We investigated α-smooth-muscle actin (α-SMA+) and CD34+ fibroblasts, density of toluidine blue-stained (MCs-TB) and tryptase-immunolabelled MCs (MCs-Try) in 30 primary breast tumours. Methods and results: Tumour (T), peri-tumoral (PT) and non-tumoral (NT) tissue was studied by immunohistochemistry and electron microscopy. MCs-TB and MCs-Try increased gradually from NT to PT and T and the comparison between the three compartments varied significantly. Degranulated MCs were present more significantly in NT and adjacent PT than T. Transition between NT, PT and T was marked by increasing α-SMA+ fibroblasts and slow disappearance of CD34+ stromal cells. In NT, CD34+ fibroblasts correlated with low density both of MCs-TB and intact MCs-Try (P=0.0346 and P=0.0409, respectively). In T, the few preserved CD34+ fibroblasts were associated with low-density degranulated MCs-Try (P=0.0173). The α-SMA+ fibroblasts correlated with high density of intact MCs-Try in PT, and with high density of degranulated MCs-Try in T (P=0.0289), also confirmed by ultrastructural analysis. Conclusions: This preliminary investigation suggests that during breast cancer progression the MCs may contribute to stromal remodelling and differentiation of myofibroblasts, through tryptase released in stromal microenvironment.

KW - α-SMA-positive myofibroblasts

KW - Breast cancer

KW - Toluidine blue

KW - Tryptase-positive mast cells

UR - http://www.scopus.com/inward/record.url?scp=79959751459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959751459&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2559.2011.03842.x

DO - 10.1111/j.1365-2559.2011.03842.x

M3 - Article

C2 - 21707711

AN - SCOPUS:79959751459

VL - 58

SP - 1096

EP - 1106

JO - Histopathology

JF - Histopathology

SN - 0309-0167

IS - 7

ER -